Skip to main content
Chart review versus an automated bioinformatic approach to assess real-world crizotinib effectiveness in ALK-positive NSCLC. JCO clinical cancer informatics Bui, N., Henry, S., Wood, D., Wakelee, H. A., Neal, J. W. 2017; 2017

View details for DOI 10.1200/CCI.16.00055

View details for PubMedID 28868517